Abstract
Current treatment options for patients with bipolar spectrum disorders are expanding. New evidence in the treatment of various phases of illness of bipolar disorder is emerging. Atypical antipsychotic medications, used as monotherapy or as adjunctive therapy with mood stabilizers, have shown efficacy as well as well-tolerated side effect profiles, thus becoming valuable new resources in the treatment of bipolar disorder.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Anticonvulsants / adverse effects
-
Anticonvulsants / therapeutic use
-
Antimanic Agents / adverse effects
-
Antimanic Agents / therapeutic use*
-
Antipsychotic Agents / adverse effects
-
Antipsychotic Agents / therapeutic use*
-
Bipolar Disorder / drug therapy*
-
Bipolar Disorder / psychology
-
Clinical Trials as Topic
-
Drug Therapy, Combination
-
Humans
-
Treatment Outcome
Substances
-
Anticonvulsants
-
Antimanic Agents
-
Antipsychotic Agents